Member Info for deltalo

Credit

Fusion Antibodies plc (AIM: FAB), specialists in pre-clinical antibody discovery, engineering and supply for both therapeutic drug and diagnostic applications, announces the receipt of an R&D tax credit from HMRC in respect of the financial year ended 31 March 2023, relating to work performed on the development and optimization of the OptiMAL® platform, as well as other R&D projects in bioinformatics, antigen design and cell culture. The value of the tax credit is in line with expectations at almost £280k, which reflects the Company's continued investment in R&D projects that maintain Fusion at the forefront of technology in the antibody market. The technologies have been well received by partners and potential partners with the OptiMAL® platform notably undergoing validation through an agreement with the National Cancer Institute in the USA. Fusion will maximise the impact of the tax credit with the generation of revenue streams from the R&D projects that were supported.

Adrian Kinkaid, CEO of Fusion, said: "The R&D tax credit system is of enormous benefit to companies developing cutting edge technologies such as we continue to do at Fusion. We are now beginning to reap the benefits of the resultant technology platforms with an elevated profile in our field and anticipate considerable commercial growth to be generated from them in the coming years."

Just the beginning of the turnaround and already this year we’ve seen two contracts and a collaboration , partnership with the NCI, National Cancer institute in the US.

Some going in Less than three months.

This year is going to be transformational for the company and for us shareholders .

Revenue will follow not far behind.

Strong buy 100 percent.

Royalties are the best option to bring in much higher revenues,

Our tech will be in very high demand globally, expect many many new contracts in all areas. Gla

Any of these?

Something big as they stated it’s a leading global provider of antibodies.

https://blog.citeab.com/who-are-the-leading-research-antibody-market-suppliers/

Any ideas who the company is that’s a leading global supplier of antibodies.

The royalties from this could be worth 10s of millions if global demand is achieved.

Definitely hard to buy any sizeable stock,

Only a matter of time before this sp moves .

Bargain price down here.

The upside from this level is huge, great new today and I expect plenty of news flow coming through in the coming weeks /months.

4m mkcap is a giveaway.

Value will start to show soon enough,

Atb.

Excellent news,

This technology is worth an absolute fortune for the company,

What a great turnaround,,

Ready for a good recovery as FAB has diversified into so many areas of interest and with huge potential also.

I also like the fact that we’ve move into the veterinary sector where there’s an amazing opportunity to increase revenue massively.

Also to be partners with the NCI is a huge milestone for the company and should bring FAB into the limelight’

Just about to begin here.

Mitchell Ho, Ph.D., Deputy Chief, Laboratory of Molecular Biology and Director of the Antibody Engineering Program, Center for Cancer Research, NCI commented: " NCI will test the OptiMAL (R) platform for the discovery of novel antibodies to cancer targets and also SARS-CoV-2. We have a particular interest in Mammalian Cell Display as a discovery engine and look forward to using this in NCI."

Richard Buick, CSO of Fusion, commented: " The expertise and experience of Dr. Ho and his colleagues make NCI an ideal partner for validation of the Optimal (R) library and mammalian cell display technology. I look forward to the collaboration and working closely with the National Cancer Institute."

Totally agree,

Just have to sit back and wait for the news flow to come through.

Added another 50k,

Make the most of these cheap shares.

Atb

Definitely the volume has picked up a lot just lately,

I’m very confident in this company and after a disappointing 2023, it looks like 2024 is going to be a very lucrative year for the company.

Watch this space.

Good to be in here.

Mkcap only 4m , this will move very fast on the next news as so many things going on in the background,

This year will see revenues flying in and so will the sp.

Interesting and very positive investors conference.

https://www.google.com/search?q=proactive+investor+fusion+antibodies+plc&ie=UTF-8&oe=UTF-8&hl=en-gb&client=safari#fpstate=ive&vld=cid:14b5e405,vid:IAvbf90GgvQ,st:0

Looking good now for a move up,

Well oversold and now very very cheap.

Buy.

Yeah,

Bargain price.

Just bought a 200k

L2 looking like a bounce up,

I see this news as a good way forward and doesn’t justify this drop.

Totally agree,

It’s going to be big.

I expecting a good day, so undervalued that I can’t buy enough of these.

Very positive encouraging outlook from the proactive one to one investor conference.

https://www.google.com/search?q=proactive+investor+fusion+antibodies+plc&ie=UTF-8&oe=UTF-8&hl=en-gb&client=safari#fpstate=ive&vld=cid:14b5e405,vid:IAvbf90GgvQ,st:0

Excellent,

A lot of cash coming our way

Should keep going up from here as revenue is increasing and we’re fully funded.

Our US partner is a huge milestone for the company.

Great buy at this level.